ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $461,970 | -68.5% | 87,000 | -43.5% | 0.06% | -34.8% |
| Q2 2023 | $1,467,620 | +109.1% | 154,000 | +141.4% | 0.09% | -1.1% |
| Q1 2023 | $701,800 | +8.3% | 63,800 | +45.7% | 0.09% | -1.1% |
| Q4 2022 | $648,240 | -99.9% | 43,800 | -6.4% | 0.09% | -29.5% |
| Q3 2022 | $894,348,000 | +99.8% | 46,800 | +122.9% | 0.13% | +111.5% |
| Q2 2022 | $447,510,000 | – | 21,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,434,232 | $162,443,000 | 13.84% |
| Bain Capital Life Sciences Investors, LLC | 3,979,292 | $76,641,000 | 7.44% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $10,960,000 | 5.19% |
| Logos Global Management LP | 1,500,000 | $28,890,000 | 3.75% |
| Omega Fund Management, LLC | 623,836 | $12,015,000 | 2.46% |
| Orbimed Advisors | 6,073,850 | $116,982,000 | 1.90% |
| MPM BioImpact LLC | 258,500 | $4,979,000 | 1.34% |
| 1492 Capital Management LLC | 75,192 | $1,448,000 | 0.77% |
| SECTORAL ASSET MANAGEMENT INC | 219,136 | $4,221,000 | 0.75% |
| EcoR1 Capital, LLC | 895,503 | $17,247,000 | 0.54% |